These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

145 related items for PubMed ID: 19176290

  • 1. New treatments for ocular hypertension.
    Mediero A, Alarma-Estrany P, Pintor J.
    Auton Neurosci; 2009 May 11; 147(1-2):14-9. PubMed ID: 19176290
    [Abstract] [Full Text] [Related]

  • 2. Adenine nucleotides and dinucleotides as new substances for the treatment of ocular hypertension and glaucoma.
    Pintor J.
    Curr Opin Investig Drugs; 2005 Jan 11; 6(1):76-80. PubMed ID: 15675606
    [Abstract] [Full Text] [Related]

  • 3. Sympathetic nervous system modulates the ocular hypotensive action of MT2-melatonin receptors in normotensive rabbits.
    Alarma-Estrany P, Crooke A, Mediero A, Peláez T, Pintor J.
    J Pineal Res; 2008 Nov 11; 45(4):468-75. PubMed ID: 18673419
    [Abstract] [Full Text] [Related]

  • 4. Requirement of intact sympathetic transmission for the ocular hypotensive effects of melatonin and 5-MCA-NAT.
    Alarma-Estrany P, Crooke A, Peral A, Pintor J.
    Auton Neurosci; 2007 Dec 30; 137(1-2):63-6. PubMed ID: 17804303
    [Abstract] [Full Text] [Related]

  • 5. Potential roles of (endo)cannabinoids in the treatment of glaucoma: from intraocular pressure control to neuroprotection.
    Nucci C, Bari M, Spanò A, Corasaniti M, Bagetta G, Maccarrone M, Morrone LA.
    Prog Brain Res; 2008 Dec 30; 173():451-64. PubMed ID: 18929127
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Incorporating corneal pachymetry into the management of glaucoma.
    Iester M, Mete M, Figus M, Frezzotti P.
    J Cataract Refract Surg; 2009 Sep 30; 35(9):1623-8. PubMed ID: 19683164
    [Abstract] [Full Text] [Related]

  • 8. Pathophysiology of glaucoma and continuous measurements of intraocular pressure.
    Sit AJ, Liu JH.
    Mol Cell Biomech; 2009 Mar 30; 6(1):57-69. PubMed ID: 19382536
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Melatonin in the eye: implications for glaucoma.
    Lundmark PO, Pandi-Perumal SR, Srinivasan V, Cardinali DP, Rosenstein RE.
    Exp Eye Res; 2007 Jun 30; 84(6):1021-30. PubMed ID: 17174303
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Adrenaline-induced chronic ocular hypertension in adult rabbits.
    Mikheytseva I, Lipovetskaya E, Kopp O, Mozaffarieh M, Grieshaber MC, Flammer J, Meyer P.
    Klin Monbl Augenheilkd; 2009 Apr 30; 226(4):332-6. PubMed ID: 19384793
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
    Casson RJ, Liu L, Graham SL, Morgan WH, Grigg JR, Galanopoulos A, Crawford A, House PH.
    J Glaucoma; 2009 Apr 30; 18(8):582-8. PubMed ID: 19826386
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Update in glaucoma medicinal chemistry: emerging evidence for the importance of melatonin analogues.
    Crooke A, Colligris B, Pintor J.
    Curr Med Chem; 2012 Apr 30; 19(21):3508-22. PubMed ID: 22709004
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. In vitro and in vivo efficacy of SYL040012, a novel siRNA compound for treatment of glaucoma.
    Martínez T, González MV, Roehl I, Wright N, Pañeda C, Jiménez AI.
    Mol Ther; 2014 Jan 30; 22(1):81-91. PubMed ID: 24025749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.